Merck KGaA announced that it has submitted an application to the European Medicines Agency (EMEA) to broaden the use of the targeted therapy Erbitux® (cetuximab) to include 1st-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN).
All about acne
What causes acne? One of the best important things you can apprentice about abscess is this:
It's not your fault. Contrary to accepted belief, abscess is not acquired by annihilation you're accomplishing — what you eat, how generally you ablution your face or assignment out — but by a aggregate of factors at assignment far below the apparent of your skin.
*NOTICE* - Anyone caught copying this site, or using our copyrighted text and/or images
without permission will be reported to their billing company, their hosting company,
and any other related companies for account closure.
We take your privacy very seriously. You can read our entire privacy policy here.
Copyright http://theacnereviews.blogspot.com/ Contact | Disclaimer All rights reserved
Designed and powered by Desouth Network.
No comments:
Post a Comment